Institute of Cellular Medicine

Staff Profile

Dr Urszula Cytlak-Chaudhuri

Research Associate

Publications

  • Bogaert DJ, Kuehn HS, Bonroy C, Calvo KR, Dehoorne J, Vanlander AV, De Bruyne M, Cytlak U, Bigley V, De Baets F, De Baere E, Rosenzweig SD, Haerynck F, Dullaers M. A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects. Journal of Allergy and Clinical Immunology 2018, 141(1), 432-435.e7.
  • Bigley V, Maisuria S, Cytlak U, Jardine L, Care MA, Green K, Gunawan M, Milne P, Dickinson R, Wiscombe S, Parry D, Doffinger R, Laurence A, Fonseca C, Stoevesandt O, Gennery A, Cant A, Tooze R, Simpson AJ, Hambleton S, Savic S, Doody G, Collin M. Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. Journal of Allergy and Clinical Immunology 2018, 141(6), 2234-2248.
  • Bigley V, Cytlak U, Collin M. Human dendritic cell immunodeficiencies. Seminars in Cell & Developmental Biology 2018, (ePub ahead of print).
  • Cytlak U, Resteu A, Bogaert D, Kuehn HS, Altmann T, Gennery A, Jackson G, Kumanovics A, Voelkerding KV, Prader S, Dullaers M, Reichenbach J, Hill H, Haerynck F, Rosenzweig SD, Collin M, Bigley V. Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. Nature Communications 2018, 9, 1239.
  • Kirkling ME, Cytlak U, Lau CM, Lewis KL, Resteu A, Khodadadi-Jamayran A, Siebel CW, Salmon H, Merad M, Tsirigos A, Collin M, Bigley V, Reizis B. Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Cell Reports 2018, 23(12), 3658-3672.e6.
  • Hannemann A, Cytlak UM, Gbotosho OT, Rees DC, Tewari S, Gibson JS. Effects of o vanillin on K+ transport of red blood cells from patients with sickle cell disease. Blood Cells, Molecules and Diseases 2014. Submitted.
  • Cytlak UM, Hannemann A, Rees DC, Gibson JS. Identification of the Ca2+ entry pathway involved in deoxygenation-induced phosphatidylserine exposure in red blood cells from patients with sickle cell disease. Pflügers Archiv-European Journal of Physiology 2013, 1-10. Submitted.
  • Gbotosho OT, Cytlak UM, Hannemann A, Rees DC, Tewari S, Gibson JS. Inhibitors of second messenger pathways and Ca2+-induced exposure of phosphatidylserine in red blood cells of patients with sickle cell disease. Pflügers Archiv-European Journal of Physiology 2013, 1-9. Submitted.
  • Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012, 51(1), 51-56. Submitted.
  • Hannemann A, Cytlak UM, Wilkins RJ, Ellory JC, Rees DC, Gibson JS. The Use of Radioisotopes to Characterise the Abnormal Permeability of Red Blood Cells from Sickle Cell Patients. In: Singh N, ed. Radioisotopes – Application in biomedical science. Croatia: InTech, 2012, pp.151-172. Submitted.
  • Dyrda A, Cytlak UM, Ciuraszkiewicz A, Lipinska A, Cueff A, Bouyer G, Egée S, Bennekou P, Lew VL, Thomas SLY. Local Membrane Deformations Activate Ca2+-Dependent K+ and Anionic Currents in Intact Human Red Blood Cells. PLoS One 2010, 5(2), e9447.